Lineage Cell Therapeutics (LCTX) Acquisitions (2010 - 2019)
Lineage Cell Therapeutics (LCTX) reported Acquisitions of $3.1 million for Q1 2019, up 966.05% quarter-over-quarter from $292387.0 in Q2 2012.
Lineage Cell Therapeutics (LCTX) Acquisitions (2010 - 2019) Analysis & Trends
Lineage Cell Therapeutics has reported Acquisitions for 4 years, with the latest figure at $3.1 million in Q1 2019.
- For the quarter ending Q1 2019, Acquisitions changed N/A year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2019 stood at $3.1 million (changed N/A YoY), and the FY2019 full-year result was $3.1 million, changed N/A from the prior year.
- Acquisitions for Q1 2019 stood at $3.1 million, up from $292387.0 in the prior quarter.
- The five-year high for Acquisitions was $3.1 million in Q1 2019, with the low at $3.1 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 3.12 Mn |
| Jun 30, 2012 | 292,387.00 |
| Sep 30, 2011 | 240,942.00 |
| Mar 31, 2011 | 5,908.00 |
| Dec 31, 2010 | 80,000.00 |